SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Alizadeh M, Bernard M, Danic B, Dauriac C, Birebent B, Lapart C, et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002; 99: 46184625.
  • 2
    Khan F, Agarwal A, Agrawal S. Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant 2004; 34: 112.
  • 3
    Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, Handgretinger R, et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 1998; 21: 487495.
  • 4
    Bader P, Klingebiel T, Schaudt A, Theurer-Mainka U, Handgretinger R, Lang P, et al. Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia 1999; 13: 20792086.
  • 5
    Dubovsky J, Daxberger H, Fritsch G, Printz D, Peters C, Matthes S, et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia 1999; 13: 20592069.
  • 6
    Gyger M, Baron C, Forest L, Lussier P, Lagace F, Bissonnette I, et al. Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host disease. Exp Hematol 1998; 26: 426434.
  • 7
    Hahn AB, Baliga P. Rapid method for the analysis of peripheral chimerism in suspected graft-versus-host disease after liver transplantation. Liver Transpl 2000; 6: 180184.
  • 8
    Nierhoff D, Horvath HC, Mytilineos J, Golling M, Bud O, Klar E, et al. Microchimerism in bone marrow-derived CD34(+) cells of patients after liver transplantation. Blood 2000; 96: 763767.
  • 9
    Pollack MS, Speeg KV, Callander NS, Freytes CO, Espinoza AA, Esterl RM, et al. Severe, late-onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis. Hum Immunol 2005; 66: 2831.
  • 10
    Bettens F, Tiercy JM, Campanile N, Giostra E, Majno P, Rubbia L, et al. Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity. Liver Transpl 2005; 11: 290297.
  • 11
    Fuchimoto Y, Yamada K, Shimizu A, Yasumoto A, Sawada T, Huang CH, et al. Relationship between chimerism and tolerance in a kidney transplantation model. J Immunol 1999; 162: 57045711.
  • 12
    Araújo MB, Leonardi LS, Boin IF, Leonardi MI, Meirelles L, Magna LA, et al. Molecular mechanisms associated with donor-specific microchimerism in peripheral blood of Brazilian patients after liver transplantation. Transplant Proc 2006; 38: 14111417.
  • 13
    Mazariegos GV, Abu-Elmagd K, Jaffe R, Bond G, Sindhi R, Martin L, et al. Graft versus host disease in intestinal transplantation. Am J Transplant 2004; 4: 14591465.
  • 14
    Hochberg EP, Miklos DB, Neuberg D, Eichner DA, McLaughlin SF, Mattes-Ritz A, et al. A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation. Blood 2003; 101: 363369.
  • 15
    Maas F, Schaap N, Kolen S, Zoetbrood A, Buno I, Dolstra H, et al. Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms. Leukemia 2003; 17: 621629.
  • 16
    Oliver DH, Thompson RE, Griffin CA, Eshleman JR. Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis. J Mol Diagn 2000; 2: 202208.
  • 17
    Jimenez-Velasco A, Barrios M, Roman-Gomez J, Navarro G, Buno I, Castillejo JA, et al. Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion/deletion polymorphisms. Leukemia 2005; 19: 336343.
  • 18
    Starzl TE. Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med 2008; 358: 407411.
  • 19
    Starzl TE, Lakkis FG. The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology 2006; 43( suppl 1): S151S163.
  • 20
    Starzl TE, Zinkernagel RM. Antigen localization and migration in immunity and tolerance. N Engl J Med 1998; 339: 19051913.
  • 21
    Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339: 15791582.
  • 22
    Starzl TE, Zinkernagel RM. Transplantation tolerance from a historical perspective. Nat Rev Immunol 2001; 1: 233239.
  • 23
    Starzl TE. Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res 2007; 38: 641.
  • 24
    Starzl TE, Murase N, Demetris AJ, Trucco M, Abu-Elmagd K, Gray EA, et al. Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation 2004; 77: 926929.
  • 25
    Beaudreuil S, Samuel D, Rouas-Freiss N, Durrbach A. New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation? Transpl Immunol 2007; 17: 98107.
  • 26
    Mazariegos GV, Sindhi R, Thomson AW, Marcos A. Clinical tolerance following liver transplantation: long term results and future prospects. Transpl Immunol 2006; 17: 114119.
  • 27
    Newell K, Larsen C. Tolerance assays: measuring the unknown. Transplantation 2006; 81: 15031509.
  • 28
    Tisone G, Orlando G, Angelico M. Operational tolerance in clinical liver transplantation: emerging developments. Transpl Immunol 2007; 17: 108113.
  • 29
    Takatsuki M, Uemoto S, Inomata Y, Egawa H, Kiuchi T, Fujita S, et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 2001; 72: 449454.
  • 30
    Bonilla WV, Geuking MB, Aichele P, Ludewig B, Hengartner H, Zinkernagel RM. Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J Clin Invest 2006; 116: 156162.
  • 31
    Lui YYN, Chik K-W, Chiu RWK, Ho C-Y, Lam CWK, Lo YMD. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 2002; 48: 421427.
  • 32
    Lui YYN, Woo K-S, Wang AYM, Yeung C-K, Li PKT, Chau E, et al. Origin of plasma cell-free DNA after solid organ transplantation. Clin Chem 2003; 49: 495496.
  • 33
    Maron J, Bianchi D. Prenatal diagnosis using cell-free nucleic acids in maternal body fluids. Am J Med Genet C Semin Med Genet 2007; 145: 517.
  • 34
    Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
  • 35
    Sykes M, Sachs DH. Mixed chimerism. Philos Trans R Soc Lond B Biol Sci 2008; 356: 707726.
  • 36
    Wood KJ. Passenger leukocytes and microchimerism: what role in tolerance induction? Transplant Proc 2003; 75( suppl): 17S20S.
  • 37
    Norris S, Lawler M, McCann S, Hegarty J, O'Farrelly C. Donor type microchimerism is an infrequent event following liver transplantation and is not associated with graft acceptance. Hepatology 1997; 26: 848852.
  • 38
    Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003; 361: 15021510.
  • 39
    Nakao A, Toyokawa H, Kimizuka K, Nalesnik MA, Nozaki I, Bailey RJ, et al. Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism. Blood 2006; 108: 14131420.
  • 40
    Alexander SI, Smith N, Hu M, Verran D, Shun A, Dorney S, et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med 2008; 358: 369374.
  • 41
    Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008; 358: 362368.
  • 42
    Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 11271152.